Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-22

Clinical Trial Update: Comparison of Combined Intravitreal Bevacizumab and Oral Acetazolamide Versus Intravitreal Bevacizumab Alone for the Treatment of Macular Edema Secondary to Retinal Vein Occlusions [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating combined intravitreal bevacizumab with oral acetazolamide versus intravitreal bevacizumab alone for macular edema due to retinal vein o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ACETAZOLAMIDE (acetazolamide)
  • Bevacizumab (bevacizumab)

Snippet

Sponsor: Shahid Beheshti University of Medical Sciences | Conditions: Macular Edema | Phase 2 | Status: UNKNOWN